T-knife Therapeutics Appoints Peggy Sotiropoulou, Ph.D. as Chief Scientific Officer
August 04, 2021 08:00 ET
|
T-knife Therapeutics
SAN FRANCISCO and BERLIN, Aug. 04, 2021 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc. a next-generation T-cell receptor company developing a pipeline of innovative therapeutics for patients with...
T-knife Therapeutics Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies
August 02, 2021 08:00 ET
|
T-knife Therapeutics
SAN FRANCISCO and BERLIN, Aug. 02, 2021 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a next-generation T-cell receptor company developing a pipeline of innovative therapeutics for solid tumor...
T-knife Therapeutics Announces the Appointment of Megan Baierlein as Chief Operating Officer
July 12, 2021 08:00 ET
|
T-knife Therapeutics
SAN FRANCISCO and BERLIN, July 12, 2021 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a next-generation T-cell receptor company developing a pipeline of innovative therapeutics for solid tumor...